Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Allergy, 2023
Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80

Ogulur I., Yazici D., Pat Y. et al.

Olink Target 96Nutritional SciencePathophysiologyCell Culture Supernatant

International Immunopharmacology, 2023
Cytokine patterns in the blister fluid and plasma of patients with fracture blisters

Li Y., Long Y., Chen X. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasmaFracture Blister Fluid

Journal of Allergy and Clinical Immunology, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics

Al-Janabi A., Martin P., Khan A. et al.

Olink Target 96Dermatological DiseasesPathophysiologySerum

Cytokine, 2023
Lower levels of Th1 and Th2 cytokines in cerebrospinal fluid (CSF) at the time of initial CSF shunt placement in children are associated with subsequent shunt revision surgeries

Simon T., Sedano S., Rosenberg-Hasson Y. et al.

Olink Target 96NeurologyPatient StratificationCSF

European Journal of Immunology, 2023
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals

Bi W., Kraft A., Engelskircher S. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Clinical and Molecular Allergy, 2023
Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention

Zakiudin D., Rø A., Videm V. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

JAMA Network Open, 2023
Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk

Sood T., Perrot N., Chong M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Hematological Oncology, 2023
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study

Hamadani M., Coleman M., Boccia R. et al.

Olink Target 96OncologyPathophysiologyPlasma

eBioMedicine, 2023
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination

Duran-Castells C., Prats A., Oriol-Tordera B. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of Circulating Biomarkers, 2023
Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™

Berggrund M., Ekman D., Gustavsson I. et al.

Olink Target 96OncologyTechnology EvaluationPlasmaVaginal Fluid

Translational Research, 2023
Plasma protein signatures reflect systemic immunity and allograft function in kidney transplantation

Buscher K., Rixen R., Schütz P. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Pulmonary Circulation, 2023
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension

Arvidsson M., Ahmed A., Säleby J. et al.

Olink Target 96CVDPatient StratificationPlasma

Frontiers in Immunology, 2023
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

Wong S., Hamidi H., Costa L. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyBone Marrow Plasma

Journal of the American Heart Association, 2023
Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study

Ali E., Syed A., Khailova L. et al.

Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma

Diabetes, Obesity and Metabolism, 2023
Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls

Verhulst C., van Heck J., Fabricius T. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

European Journal of Neurology, 2023
Paraneoplastic or not? Sirtuin 2 in anti‐N‐methyl‐d‐aspartate receptor encephalitis

Stevens‐Jones O., Mojzisova H., Elisak M. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPatient StratificationCSF

Cardiovascular Research, 2023
A machine learning based approach to identify carotid subclinical atherosclerosis endotypes

Chen Q., Bergman O., Ziegler L. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of Dermatological Science, 2023
Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis

Deng J., Leijten E., Zhu Y. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Neurological Research and Practice, 2023
Novel inflammatory biomarkers associated with stroke severity: results from a cross-sectional stroke cohort study

Braadt L., Naumann M., Freuer D. et al.

Olink Target 96CVDPatient StratificationSerum

Science Translational Medicine, 2023
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma

Schmassmann P., Roux J., Buck A. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

1889 publications